Inducing Hyperlipidemia to Characterize Diastolic Dysfunction in HFpEF Mice

320 Views

•

01:48 min

•

March 29th, 2024

DOI :

10.3791/201537-v

March 29th, 2024

•

Monique Williams¹^,², Ali Kamiar²^,³, Jose Manuel Condor Capcha¹^,², Monica Anne Rasmussen⁴, Qusai Alitter², Rosemeire Kanashiro Takeuchi²^,³, Lauro Mitsuru Takeuchi², Joshua M. Hare¹^,², Lina A. Shehadeh¹^,²

¹Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, ²Interdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, ³Department of Molecular and Cellular Pharmacology, University of Miami Leonard M. Miller School of Medicine, ⁴Department of Medical Education, University of Miami Leonard M. Miller School of Medicine

Explore More Videos

Tail Vein Injection

Peritoneal Injection

Echocardiography

Diastolic Dysfunction

Mitral Flow Velocity

Mitral Annular Velocity

From the series

Investigating HFpEF Pathophysiology in a Hyperlipidemia-Induced Mouse Model

Copyright © 2025 MyJoVE Corporation. All rights reserved